Autopsy report · NCT03318250
TransGrade Multimodal Neuromodulation of the Dorsal Root Ganglion Ensemble for Refractory Neuropathic Pain
Cause of deathFunding or business
“Study terminated early at the request of Sponsors.”
Life of this trial
- Registered 8 months before it started.
- Ran for about 4 years before it stopped.
- 24 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Sponsor type
- University, hospital or other
- Conditions
- Neuropathic Pain; Pain, Chronic
- Interventions
- Dorsal Root Ganglion Stimulation
- Participants
- 24
- Sites
- 1
- Countries
- United Kingdom
Trials that died the same way
- Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
“Study terminated at Sponsor's request.” - Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
“Study terminated by the Sponsor” - A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
“The study was terminated early as per Sponsor's decision” - An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa
“The sponsor decided to terminate the study early” - Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer
“Study Terminated by Sponsor”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.